Stock UniverseDerived research view · source repositories remain read-only

Amgen Inc. (AMGN)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - General
Score Band
Qualified
Selection Score
36.31
Global Rank
1027
Market Cap
209.24B
Latest Close
349.58
RS Composite
-3.10% · G#1617

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
6.38%
3M
-4.68%
6M
2.68%
1Y
25.46%
3Y
73.72%
5Y
71.97%
10Y
198.21%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 3.45M · 30-day average: 2.64M · Max drawdown over stored range: -24.86%

Research Snapshot

Relative Strength vs SPX

RS Composite-3.10%
20D RS6.39%
60D RS-15.70%
120D RS4.75%
Global RS Rank1617 · 51.80% percentile
Qualified+ RS Rank581 · 53.82% percentile
Group ScopeQualified+
Primary RS Rank156 · 65.94% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank180 / 701
Primary Percentile74.47
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-0137.22Bn/a10.57B7.80B14.3815.82B3.35B12.47B542Mn/a28.39%20.96%42.50%33.50%12.04B51.89B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$14.3824.3x$68.645.1x$22.9915.2x$29.1712.0x

Shares Diluted: 542M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue2597926323281903342436751
Revenue Growth (YoY)2.183%1.324%7.093%18.567%9.954%
Gross Profit1952519947203952296626014
Operating Income9151100989823967611574
Free Cash Flow838187857359103948100
Free Cash Flow Per Share14.62716.23813.67819.21314.945
EPS (Diluted) GAAP10.2812.1112.497.5614.23
EPS Growth-16.491%17.802%3.138%-39.472%88.228%
EPS Non-GAAP
Gross Margin75.157%75.778%72.348%68.711%70.784%
Operating Margin35.225%38.362%34.846%28.949%31.493%
Profit Margin22.684%24.891%23.828%12.237%20.982%
Free Cash Flow Margin32.261%33.374%26.105%31.097%22.04%
Shares Outstanding (Diluted)573541538541542
Shares Change (YoY)-2.881%-5.585%-0.555%0.558%0.185%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-018.62Bn/a2.67B30.94%1.82B21.11%3.34544.00M12.04B51.89Bprocessed
2025 Q42026-02-139.87Bn/a2.72B27.57%1.33B13.51%2.46542.00M9.13B50.01Bprocessed
2025 Q32025-11-059.56Bn/a2.53B26.43%3.22B33.65%5.93542.00M9.45B52.43Bprocessed
2025 Q22025-08-069.18Bn/a2.66B28.94%1.43B15.60%2.65541.00M8.03B53.76Bprocessed
2025 Q12025-05-028.15Bn/a1.18B14.46%1.73B21.23%3.20541.00M8.81B54.01Bprocessed
2024 Q42025-02-149.09Bn/a2.31B25.43%627.00M6.90%1.16541.00M11.97B56.55Bprocessed
2024 Q32024-10-318.50Bn/a2.05B24.07%2.83B33.28%5.22542.00M9.01B56.85Bprocessed
2024 Q22024-08-078.39Bn/a1.91B22.76%746.00M8.89%1.38541.00M9.30B57.12Bprocessed
2024 Q12024-05-037.45Bn/a991.00M13.31%-113.00M-1.52%-0.21536.00M9.71B60.06Bprocessed
2023 Q42024-02-148.20Bn/a1.27B15.51%767.00M9.36%1.43538.00M10.94B63.17Bprocessed
2023 Q32023-10-316.90Bn/a2.02B29.28%1.73B25.06%3.22538.00M34.74B59.04Bprocessed
2023 Q22023-08-046.99Bn/a2.68B38.42%1.38B19.74%2.57537.00M34.25B59.38Bprocessed
2023 Q12023-04-286.11Bn/a1.92B31.47%2.84B46.54%5.28538.00M31.56B60.76Bprocessed
2022 Q42023-02-096.84Bn/a2.23B32.61%1.62B23.63%3.00538.00M7.63B37.35Bprocessed
2022 Q32022-11-046.65Bn/a2.66B39.99%2.14B32.22%3.98538.00M9.50B37.16Bprocessed
2022 Q22022-08-056.59Bn/a2.18B33.00%1.32B19.97%2.45537.00M5.20B35.70Bprocessed
2022 Q12022-04-286.24Bn/a2.50B40.08%1.48B23.66%2.68551.00M6.53B36.01Bprocessed
2021 Q42022-02-166.85Bn/a2.30B33.65%1.90B27.74%3.37564.00M7.99B33.22Bprocessed
2021 Q32021-11-036.71Bn/a2.38B35.46%1.88B28.09%3.31570.00M11.97B33.29Bprocessed
2021 Q22021-08-046.53Bn/a828.00M12.69%464.00M7.11%0.81576.00M6.63B28.46Bprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.